Mresvia Dosage
Generic name: RNA-100-AR02 50ug in 0.5mL
Dosage form: injection
Drug class: Viral vaccines
Medically reviewed by drugclasses.com. Last updated on May 31, 2024.
Preparation for Administration
MRESVIA is supplied as a pre-filled syringe that contains a frozen suspension that must be thawed prior to administration.
Thaw each syringe before use, either in the refrigerator or at room temperature, following the instructions in Table 1.
Configuration | Thaw in Refrigerator | Thaw at Room Temperature |
---|---|---|
Carton of one pre-filled syringe in single blister pack |
Thaw between 2°C to 8°C (36°F to 46°F) for 60 minutes. Let each pre-filled syringe stand at room temperature for between 10 and 20 minutes before administering the vaccine. |
Thaw between 15°C to 25°C (59°F to 77°F) for 45 minutes. If MRESVIA is thawed at room temperature, the vaccine is ready to be administered. |
Carton of 10 pre-filled syringes in blister packs |
Thaw between 2°C to 8°C (36°F to 46°F) for 155 minutes. Let each pre-filled syringe stand at room temperature for between 10 and 20 minutes before administering the vaccine. |
Thaw between 15°C to 25°C (59°F to 77°F) for 140 minutes. If MRESVIA is thawed at room temperature, the vaccine is ready to be administered. |
- •
- After thawing, do not refreeze.
- •
- Do not shake. Syringes should not be returned to the refrigerator after standing at room temperature.
- •
- Pre-filled syringes may be stored at 8°C to 25°C (46°F to 77°F) for a total of 24 hours after removal from refrigerated conditions. Discard the thawed pre-filled syringe if not used within this time.
- •
- Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.
- •
- MRESVIA is a white to off-white suspension that may contain visible white or translucent product-related particulates. Do not administer if the vaccine is discolored or contains other particulate matter.
More about mRESVIA (rsv vaccine, mrna)
- Check interactions
- Compare alternatives
- Drug images
- During pregnancy
- FDA approval history
- Drug class: viral vaccines
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.